Latest filing published 02 Mar 2023 for Emergent BioSolutions Inc., €8,050.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Katherine Strei: trading record in brief
All filings by Katherine Strei on record concern Emergent BioSolutions Inc., in the capacity of senior executive. We count 36 filings; the first trade dates from 27 February 2018 and the latest from 28 February 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 2 March 2023: a share grant of €8,050, in Emergent BioSolutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Katherine Strei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 690 shares@ US$12.3831.4% of flowCommon StockSEC:0001367644-23-000056:0
- 352 shares@ US$14.3018.5% of flowCommon StockSEC:0001367644-23-000038:0
- 61 shares0Common StockSEC:0001367644-23-000016:0
- 24,167 shares0Common StockSEC:0001367644-22-000040:0
- 344 shares@ US$42.2350.1% of flowCommon StockSEC:0001367644-22-000034:0
- 1,258 shares0Common StockSEC:0001367644-22-000014:0
6 of 6 declarations
